French chemicals firm, Rhodia (BBB-, stable/Baa3, negative) is still a name listed on the new issue pipeline, but it seems the market may be waiting in vain for the borrower to launch its planned €300-€500 million deal.

Lead managers BNP Paribas, HSBC and Fortis say the deal has been postponed and they are unable to provide any new information, blaming the high-yield premium demanded by investors for the postponement. But some wonder whether the deal will actually surface at all.


Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

If you already have an account, please sign in here.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here